-
People from the pharmaceutical industry across the Straits call for strengthening cooperation in new drug research and development
Time of Update: 2016-03-21
The second cross strait biotechnology and new drug industry cooperation and exchange meeting was held in Beijing on March 21-22, with more than 20 major new drug enterprises from both sides participat
-
Kunming Plant Research Institute and grace company transfer the anticoagulant new drug LFG project to Jiuzhitang
Time of Update: 2016-03-17
Jiuzhitang (000989) announced in the evening of March 17 that the company signed the project transfer contract with Kunming Institute of Botany, Chinese Academy of Sciences (hereinafter referred to as
-
US $65 million of Fudan University's patent for immunooncology drugs was transferred to Huya
Time of Update: 2016-03-16
On March 15, Professor Yang Qing of School of life sciences of Fudan University and vice president Jin Li of Fudan University reached an agreement in Shanghai between Fudan University and Huya (Shangh
-
CDE drug review weekly report (March 7, 2016 to March 13, 2016)
Time of Update: 2016-03-14
This week, no new 1.1 kinds of drugs have entered the state of review, and the 1.1 category of the essence medicine has been reviewed by the drug group The Tianjin Institute of pharmacy has approved t
-
The first new drug to be launched simultaneously in China and the United States is expected to be born
Time of Update: 2016-03-11
On March 10, Wuxi Pharmaceutical Co., Ltd and Lilly, an American pharmaceutical giant, announced in Shanghai that they would jointly develop, produce and commercialize a new small molecule oral lipid-
-
Announcement of Hisilicon on the first clinical approval of hsk3486, a new chemical drug of category 1.1
Time of Update: 2016-03-09
Securities code: 002653 securities abbreviation: hysic Announcement No.: 2016-017 announcement of hysic Pharmaceutical Group Co., Ltd on obtaining the first class 1.1 clinical approval of new chemical
-
Drugs at the forefront of internationalization of traditional Chinese Medicine
Time of Update: 2016-03-08
Chinese medicine is the treasure of the Chinese nation, reflecting the great wisdom of the Chinese nation Internationalization of traditional Chinese medicine is the way to show China to the world, an
-
CDE drug review weekly report (February 29, 2016 to March 6, 2016)
Time of Update: 2016-03-07
This week, two types of 1.1 chemicals developed by Shanghai Pharmaceutical Research Institute entered the evaluation stage, and fcn-411 capsule of Fosun Pharmaceutical and tq-b3234 capsule of Zhengda
-
Is it really useless to compete for the first imitation?
Time of Update: 2016-03-07
In March 2016, the drug review center of the State Food and Drug Administration issued the 2015 drug review report In 2015, the number of chemical validation clinical approvals reached 2050 Such a hig
-
Hcp002, a class 1.1 anti infective new drug, gained clinical approval
Time of Update: 2016-03-04
Shaanxi Synthetic Pharmaceutical Co., Ltd (hereinafter referred to as "the company") has applied for a new chemical drug of category 1.1, "hcp002 and hcp002 for injection", which has obtained the appr
-
Donafinil toluenesulfonate, a new chemical antitumor drug of Zejing biological 1.1, landed in Kunshan
Time of Update: 2016-03-04
A new anti-tumor drug with independent intellectual property rights will be launched in Suzhou Yesterday, Sheng Zelin, general manager of Suzhou Zejing biopharmaceutical Co., Ltd., announced the good
-
Train of thought: hand in hand with Corning Jerry to develop PD-L1 new drug
Time of Update: 2016-03-02
On February 29, thoughtway and Corning Jerry signed a cooperation agreement to develop the first new generation PD-L1 all human monoclonal antibody independently innovated and developed in China Accor
-
Kangzhe Pharmaceutical Co., Ltd. won the distribution license of AstraZeneca hypertension drug Boying in China for us $310 million
Time of Update: 2016-03-01
"/ > kangzhe Pharmaceutical (00867-hk) announcement, and AstraZeneca AB signed an exclusive license agreement, and the company was granted the exclusive right to commercialize the licensed product of
-
AstraZeneca submits the listing application of linaclonide, a new constipation drug, to CFDA
Time of Update: 2016-03-01
Ironwood and its partner, Asteris, recently announced that they have submitted an application to the Ministry of health, labor and welfare of Japan (MHLW) for the listing of linaclonide, a new constip
-
Gst-hg131: a new hepatitis B drug developed by guangshengtang and Wuxi apptec
Time of Update: 2016-02-29
Guangshengtang announced in the evening of February 28 that recently, the company and Wuxi apptec signed a "cooperative development contract" for "research and development of new hepatitis B drug gs-h
-
CDE drug review weekly report (February 22, 2016 to February 27, 2016)
Time of Update: 2016-02-29
Four 1.1 and 40 3.1 chemicals have entered the review stage this week, and 23 of 3.1 chemicals are in good weather! In addition, four new 1.1 chemicals were added this week and approved Key chemicals
-
Clinical approval of raw materials and tablets of ruracidone hydrochloride
Time of Update: 2016-02-27
Shisiyao group (02005 HK) announced that it has obtained the approval documents for drug registration and clinical trials issued by the State Food and Drug Administration on the raw materials and tabl
-
Kangfang biology: developing innovative antibody new drugs in the form of strategic cooperation
Time of Update: 2016-02-27
Im portant;" ALT = "" / > 26, "economic vitality: Guangdong transformation and upgrading" Media Group entered kangfang biomedical company Zheng Lei, a reporter from xinhuanet.com, took a picture of the local document provided by the editor "style =" margin: 0px; padding: 0px; border: 0px solid RGB (0, 0, 0); vertical align: middle; cursor: URL (http:// Cur), auto; height: Auto!
-
Drugs approved for marketing in China in 2015: first imitation, new dosage form and new compound!
Time of Update: 2016-02-27
CFDA announced the approval of Chinese drugs for listing in 2015 on February 22 According to statistics, in 2015, CFDA approved 241 chemical drugs, 25 biological products, and 76 traditional Chinese m
-
Inventory of traditional Chinese medicine and natural medicine approved for marketing in 2015
Time of Update: 2016-02-26
Recently, CFDA released the approval of drug listing in 2015 According to statistics, in 2015, the State Food and Drug Administration approved 76 applications for listing registration of traditional C
